Alexion Pharmaceuticals Inc (ALXN.O)


ALXN.O on Nasdaq

92.22USD
14 Jun 2013
Price Change (% chg)

$-1.19 (-1.27%)
Prev Close
$93.41
Open
$92.95
Day's High
$93.43
Day's Low
$91.13
Volume
940,812
Avg. Vol
1,459,627
52-wk High
$119.54
52-wk Low
$81.82

ALXN.O

Chart for ALXN.O

About

Alexion Pharmaceuticals, Inc. (Alexion) is a biopharmaceutical company focused on serving patients with severe and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products. Its marketed product Soliris (eculizumab) is the first and only therapeutic approved for patients with... (more)

Overall

Beta: 0.48
Market Cap (Mil.): $18,029.60
Shares Outstanding (Mil.): 195.15
Dividend: --
Yield (%): --

Financials

  ALXN.O Industry Sector
P/E (TTM): 63.38 30.37 30.65
EPS (TTM): 1.46 -- --
ROI: 14.39 19.50 18.83
ROE: 17.66 20.27 19.74
Search Stocks

Latest News about ALXN.O

BRIEF-Alexion Pharmaceuticals shares up 3.1 percent in premarket trade following results

NEW YORK, April 25 - Alexion Pharmaceuticals Inc : * Shares up 3.1 percent in premarket trade following results

25 Apr 2013
» More ALXN.O News

Competitors

  Price Change
Johnson & Johnson (JNJ.N) $86.16 -0.20
Abbott Laboratories (ABT.N) $36.88 -0.63
Sanofi SA (SASY.PA) €81.27 -0.28
Bristol Myers Squibb Co. (BMY.N) $46.55 -0.30
Bristol Myers Squibb Co. (BMYMP.PK) -- --
Amgen, Inc. (AMGN.OQ) $101.54 +0.04

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Thomson Reuters Stock Report - ALEXION PHARMACEUTICALS, INC. (ALXN-O)
Provider: Thomson Reuters Stock Report
$25.00
Buy
Market Edge Equity Research Report
Provider: Market Edge
$10.00
Buy
Alexion Pharmaceuticals
Provider: S&P Capital IQ – STARS Reports
$115.00
Buy
Alexion Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
$20.00
Buy
Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ALEXION PHARMACEUTICALS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.
Provider: Jefferson Research
$20.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research
Search Stocks